| Identification | Back Directory | [Name]
2(1H)-Pyrimidinone, 4-amino-1-(2,3-dideoxy-β-D-erythro-hexopyranosyl)- (9CI) | [CAS]
136020-18-3 | [Synonyms]
1-(2,3-Dideoxy-b-D-erythro-hexo pyranosyl)cytosine
1-(2,3-Dideoxy-β-D-erythro-hexo pyranosyl)cytosine
2(1H)-Pyrimidinone, 4-amino-1-(2,3-dideoxy-β-D-erythro-hexopyranosyl)- (9CI) | [Molecular Formula]
C10 H15 N3 O4 | [MOL File]
136020-18-3.mol | [Molecular Weight]
241.25 |
| Hazard Information | Back Directory | [Uses]
1-(2,3-Dideoxy-β-D-erythro-hexo pyranosyl)cytosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|